Kimia Biosciences Limited (BOM:530313)
27.92
+0.74 (2.72%)
At close: Aug 21, 2026
Kimia Biosciences Revenue
Kimia Biosciences had revenue of 207.23M INR in the quarter ending June 30, 2026, a decrease of -12.13%. This brings the company's revenue in the last twelve months to 1.12B, down -6.73% year-over-year. In the fiscal year ending March 31, 2026, Kimia Biosciences had annual revenue of 1.15B, down -3.39%.
Revenue (ttm)
1.12B
Revenue Growth
-6.73%
P/S Ratio
1.18
Revenue / Employee
4.48M
Employees
250
Market Cap
1.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.15B | -40.37M | -3.39% |
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.08B |
| Resonance Specialties | 1.02B |
| Tyche Industries | 500.33M |
| Auro Laboratories | 364.26M |
| Vasundhara Rasayans | 347.79M |
| Crestchem | 338.33M |